Health Care/Hospital

Nuance Pharma Announces Publication of Phase 3 ENHANCE-CHINA Data in the CHEST Journal

Ohtuvayre® (ensifentrine) helped improve lung function in Chinese adult patients in in data published in peer reviewed journal SHANGHAI, April 20, 2026 /PRNewswire/ -- Nuance Pharma ("Nuance" or the "Company") announces that CHEST, the official journal of the American College of Chest Physicians...

2026-04-20 09:00 3696

Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)

•  The one-year INFUSE study observed patient-reported migraine-related cognitive symptoms at baseline and changes over 6 months in those with at least one prior anti-calcitonin gene-related peptide (anti-CGRP) treatment failure VALBY, Denmark, April 20, 2026 /PRNewswire/ -- H. Lundbeck A/S (Lund...

2026-04-20 01:29 3688

BREAKTHROUGH PRIZE ANNOUNCES 2026 LAUREATES

Six $3 Million Prizes Awarded for Outstanding Discoveries in Life Sciences, Fundamental Physics and Mathematics Gene Therapies for Inherited Blindness, Sickle Cell Disease and Beta-Thalassemia Discovery of Key Genetic Cause of ALS and Frontotemporal Dementia Precision Measurement of Muon's Magn...

2026-04-19 10:38 2647

Ddrops® Supports Children's Healthy Growth at Dripping Colours Montessori Sports Day -- Every Step Toward a Healthier Future

KUALA LUMPUR, Malaysia, April 18, 2026 /PRNewswire/ -- Ddrops® participated in the annual Sports Day hosted by Dripping Colours Montessori on April 18, 2026, reinforcing its commitment to supporting children's healthy growth through active lifestyles and proper ...

2026-04-18 20:00 5534

Antengene Presents Three Novel Programs at AACR 2026, Highlighting Next-Generation ADC and AnTenGager® TCEs

SHANGHAI and HONG KONG, April 18, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune ...

2026-04-18 08:30 6178

ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds

MUNICH, April 18, 2026 /PRNewswire/ -- The largest real-world study of its kind, presented today at ESCMID Global 2026, shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the risk of hospitalisation in young infants by over 80% when given at least two weeks before b...

2026-04-18 06:01 5364

NYSE Content Update: Defense Tech Company AEVEX to Make Its Public Debut

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, April 17, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begi...

2026-04-17 21:42 8854

World Hemophilia Day 2026 - April 17, 2026 - "Diagnosis: First step to care."

MONTREAL, April 17, 2026 /PRNewswire/ -- On April 17, 2026, the global inherited bleeding disorders community will come together on World Hemophilia Day to advocate for all inherited bleeding disorders. This year's theme of  "Diagnosis: First step to care" highlights the critical importance of di...

2026-04-17 13:00 2933

How IBM Quantum is Enabling Healthcare and Biology Research

In the first ever Q4Bio Challenge, research teams sought to demonstrate scalable quantum algorithms for healthcare, with Algorithmiq's work alongside Cleveland Clinic and IBM earning $2 million Q4Bio prize. * Q4Bio aims to accelerate development of quantum algorithms for healthcare that can ru...

2026-04-17 03:09 3653

DOJ Drops All Charges Against Vasudha

The company welcomes dismissal of the case after maintaining its innocence for more than a year HYDERABAD, India, April 17, 2026 /PRNewswire/ -- Vasudha Pharma Chem Limited ("Vasudha" or the "Company"), a leading pharmaceutical bulk drug and intermediate manufacturing company, announced today th...

2026-04-17 02:32 3741

Milliken & Company Releases 2025 Sustainability Report

SPARTANBURG, S.C., April 17, 2026 /PRNewswire/ -- Milliken & Company released its 2025 Sustainability Report, detailing progress across people, planet, and business conduct, marking the company's eighth consecutive year of sustainability reporting.

2026-04-17 00:12 4959

Frost & Sullivan Celebrates Industry Leaders at the 2026 Best Practices Recognition Gala

Recognizing companies for excellence, innovation, and business impact SAN ANTONIO, April 16, 2026 /PRNewswire/ -- Industry trailblazers convened in Fort Lauderdale, Florida, for the 2026 Frost & Sullivan Best Practices Gala, held at the Marriott Harbor Beach Resort & Spa. The event brought togeth...

2026-04-16 21:00 3460

Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

* Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™. * The new brand structure reflects the scientific journey, connecting early discoveries to translational...

2026-04-16 20:49 3911

Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026

SAN DIEGO and NEW YORK, April 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System, one of the leading academic health systems in the United States, will adopt the AI-powered SOPHiA DDM™ Platfo...

2026-04-16 20:00 3785

After 35 Years with Parkinson's Disease and a Life-Threatening Infection, One Patient Reclaimed Independent Living

SHANGHAI, April 16, 2026 /PRNewswire/ -- On World Parkinson's Day, Jiahui International Hospital shares an extraordinary case highlighting advanced Parkinson's disease care complexity, multidisciplinary collaboration, and functional recovery despite life‑threatening complications. A 75‑year‑old ...

2026-04-16 18:59 2790

Mabwell Establishes a Licensing and Commercialization Agreement for Denosumab Biosimilars in Malaysian Market

SHANGHAI, April 16, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has established a licensing and commercialization agreement with a strategic business partner ("the partner") in Malaysia for its...

2026-04-16 17:00 5510

First Ever APAC Pharmacists' Guideline to Tackle Peripheral Neuropathy

Developed By APAC Pharmacist Experts -  1 in 2 diabetics, and 1 in 10 adults suffer from Peripheral Neuropathy [1],[2] -  Community pharmacists first and most accessible point of healthcare contact -  New guidelines highlight emerging role of pharmacists in elevating the standard of care SIN...

2026-04-16 12:00 3605

SMU launches Longevity Societies and Economies Institute to advance knowledge and innovation for Singapore's longevity transition

New institute will consolidate SMU's ageing-related research and drive an interdisciplinary agenda to build resilient and opportunity-rich longevity societies and economies SINGAPORE, April 16, 2026 /PRNewswire/ -- Singapore Management University (SMU) has launched the SMU Longevity Societies an...

2026-04-16 12:00 4190

Global First | NMPA Accepts IND Application for Mabwell's Innovative LILRB4/CD3 TCE Bispecific Antibody 6MW5311

SHANGHAI, April 16, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the National Medical Products Administration (NMPA) has accepted the Investigational New Drug (IND) application for its innovative L...

2026-04-16 11:36 5754

Mabwell Announces Acceptance of Supplemental Biologics License Application by NMPA for MAIWEIJIAN (Denosumab)

SHANGHAI, April 16, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with a full industry chain, announced that the National Medical Products Administration (NMPA) has accepted supplemental Biologics License Application for MAIWEIJIAN (denosumab injection, R&D cod...

2026-04-16 08:00 4412
1 ... 11121314151617 ... 541